Phase 1 Celiac Disease Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Celiac Disease
Nielsen Fernandez-Becker20 enrolled1 locationNCT07377565
Recruiting
Phase 1
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
HealthyCeliac Disease
Nielsen Fernandez-Becker18 enrolled1 locationNCT07063823
Completed
Phase 1
A Randomized, Double-blind, Placebo-controlled Phase I Study of Subcutaneous EQ102 Administered in a Single and Multiple Ascending Dose Schedule
Celiac Disease
Equillium AUS PTY Ltd72 enrolled2 locationsACTRN12622001449729
Completed
Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability in Patients With Celiac Disease
Celiac Disease
ImmusanT, Inc84 enrolled1 locationACTRN12612000355875